Novartis Settles Lawsuit with Henrietta Lacks Estate Over Unauthorized Use of HeLa Cells in Research

Pharmaceutical giant Novartis has settled a lawsuit with the estate of Henrietta Lacks regarding the unauthorized use of her "stolen" cells in medical research.

By: AXL Media

Published: Feb 28, 2026, 10:25 AM EST

Source: Information for this report was sourced from MedPage Today

Legal Basis of the "Unjust Enrichment" Claim

The lawsuit filed by the estate of Henrietta Lacks centered on the legal theory of "unjust enrichment." The estate argued that Novartis knowingly utilized the HeLa cell line, which was harvested without Lacks’ knowledge or consent at Johns Hopkins Hospital, to develop and profit from numerous medical treatments and diagnostic tools. By reaching a settlement, Novartis avoids a protracted legal battle over the ethics of utilizing biological materials obtained through historic medical practices that did not adhere to modern standards of informed consent.

The Legacy of HeLa Cells in Modern Medicine

The HeLa cell line is unique for its ability to reproduce indefinitely in a laboratory setting, making it the first "immortal" human cell line. Since 1951, these cells have been foundational to some of the most significant breakthroughs in medicine, including the development of the polio vaccine, gene mapping, and advancements in cancer and COVID-19 research. While the medical community has benefited immensely from the HeLa line, the Lacks family has long advocated for acknowledgment that these contributions were made possible through an act they characterize as a violation of bodily autonomy and racial justice.

+2

Corporate Responsibility and Bioethical Evolution